Denmark's Prime Minister Mette Frederiksen had summoned business leaders after speaking on Wednesday with U.S.

The CEO of obesity drug manufacturer Novo Nordisk and heads of other Danish companies were expected to discuss preparations ...

We recently published a list of These 10 Firms Took A Hit on Friday. In this article, we are going to take a look at where ...

The head of Ozempic maker Novo Nordisk A/S is among business executives who are meeting the Danish prime minister to discuss ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs ...

In a report released today, James Quigley from Goldman Sachs maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price ...

On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No ...

That’s right—the insanely popular diabetes and weight-loss drugs are Danish in origin, from the big pharmaceutical company ...

UBS analyst Jo Walton maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK750.00. The company’s ...

Novo Nordisk's financial strength is evident through its 74% historical average ROIC and 85% gross margin. See why I rate NVO ...